YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Fresh attention on Sartorius (XTRA:SRT3) comes after a 281 page Research and Markets study on cell based assays named the group among 54 profiled life science suppliers. The latest share price of €260.0 comes after a 30 day share price ret…
Company Logo 281-Page Report Tracks Post-Pandemic Research Growth Across Pharma, Research and Industry/Cosmetic Users as 3D Assays, Automation and Immuno-oncology Reshape Drug Discovery Dublin, Oct. 07, 2026 (GLOBE NEWSWIRE) -- "Cell-Based…
Company Logo Opportunities include automated closed systems, AI-enabled quality control, single-cell and cell therapy workflows, precision medicine, advanced diagnostics and emerging-market expansion. Dublin, Sept. 24, 2026 (GLOBE NEWSWIRE…
Company Logo Reusable Bioreactors Gain Momentum as Biologics, Personalized Therapies and Vaccine Production Drive Automation and Scalable Manufacturing Dublin, Sept. 24, 2026 (GLOBE NEWSWIRE) -- "Reusable Bioreactors Market Opportunity, Gr…
Company Logo Cell Culture Media Market Gains Momentum as Serum-Free Formulations, Biologics and Cell Therapies Drive Demand Dublin, Sept. 24, 2026 (GLOBE NEWSWIRE) -- "Cell Culture Media Market Opportunity, Growth Drivers, Industry Trend A…
Company Logo Biologics, stricter purity rules and flexible manufacturing are driving demand for single-use, automated and continuous filtration, advanced membranes and sustainable systems. Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Pharma…
Company Logo Bioreactors Market Gains Momentum as Single-Use Systems, Automation and Advanced Therapies Reshape Biomanufacturing Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "Bioreactors Market Opportunity, Growth Drivers, Industry Trend Ana…
Company Logo Europe's cell therapy sector is shifting to closed, automated systems, creating opportunities in AI monitoring, modular scale-up, CAR-T/ATMP production and decentralized manufacturing Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) --…
Company Logo Demand is rising for real-time biomolecular analysis in drug discovery and diagnostics, driven by SPR/BLI advances, automation, high-throughput screening and biomarker research. Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "Labe…
Company Logo AI-enabled, microfluidic label-free detection is expanding in drug discovery, early diagnostics, food safety and environmental testing, driven by efficient, non-invasive, sustainable workflows. Dublin, Sept. 22, 2026 (GLOBE NE…
Company Logo Demand is rising for single-use, automated and real-time aseptic sampling as biopharma and food producers prioritize contamination control, continuous manufacturing and compliance. Dublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "A…
Sartorius (XTRA:SRT3) has drawn fresh attention after announcing a partnership with Ireland's National Institute for Bioprocessing Research and Training to build a large-scale training center for intensified and fully continuous bioprocess…
Company Logo Opportunities center on real-time, high-throughput drug discovery and diagnostics, driven by SPR/BLI advances, AI analytics, CRO adoption, improved sensitivity and Asian localization. Dublin, Sept. 16, 2026 (GLOBE NEWSWIRE) --…
Company Logo The global single-use bioreactors market is forecast to grow from USD 5.43 billion in 2026 to USD 9.58 billion by 2031, at a 12.0% CAGR. Growth is driven by biologics, biosimilars, vaccine manufacturing, CDMO outsourcing, and…
Company Logo The global Advanced Bioreactor Systems Market is projected to grow from USD 4.2 billion in 2026 to USD 11.8 billion by 2036, at a CAGR of 10.9%. Growth is driven by biologics manufacturing, cell and gene therapies, single-use…
When biopharmaceutical suppliers report earnings, ripples move fast across the sector. On July 21, Danaher Corporation (NYSE:DHR) reported its Q2 2026 results. While the life sciences giant continues to lead in financial scale, its bioproc…
This article first appeared on GuruFocus. Group Sales Revenue: Increased by 7.7% on an operational basis in constant currencies for H1 2026. Bioprocess Solutions Growth: 8.3% growth on an operational basis in constant currencies. Lab Produ…
Company Logo Biopharmaceutical production led applications in 2025, while sera, media and reagents dominated consumables. Asia-Pacific is expected to record the fastest growth through 2031. Key players include Thermo Fisher Scientific, Dan…
Thermo Fisher stock led a medtech rebound Thursday, easing investors' fears of continued malaise for the medical research and tools realm. Continue Reading
Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Bioprocess Digital Twin Market size & share revenue was valued at approximately USD 0.…
Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Cell Therapy Human Raw Materials Market size & share revenue was valued at approximate…
Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Stem Cell Culture Media Market size & share revenue was valued at approximately USD 76…
Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Laboratory Equipment Services Market size & share revenue was valued at approximately…
Danaher Corporation (NYSE:DHR) is one of the top high-conviction stocks to buy according to hedge funds. HSBC cut the price target on Danaher Corporation (NYSE:DHR) to $230 from $270 on June 3 and maintained a Buy rating on the shares. The…
Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Bioprocess Automation Software Market size & share revenue was valued at approximately…
On May 18, 2026, Elliott Investment Management disclosed a significant stake in Bio-Rad Laboratories and began pressing for changes to improve shareholder outcomes, focusing in part on the company’s large holding in Sartorius, valued at ab…
This article first appeared on GuruFocus. Elliott Investment Management has reportedly built a sizable stake in Bio-Rad Laboratories (NYSE:BIO), putting fresh activist pressure on a life-science tools supplier whose share price has been un…
Sartorius opens new competence center for cell and gene therapy components in Freiburg, Germany Manufacturing capacity for quality-critical materials for the dynamic cell and gene therapy market more than doubled Opening ceremony in the Ha…
[Global Commerce and Business logistics] Stock index futures fell Monday as traders awaited Nvidia (NVDA [https://seekingalpha.com/symbol/NVDA]) and retail earnings reports slated to come later in the week. Now, here are 5 news stories tha…
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Recent share performance and business snapshot Sartorius (XTRA:SRT3) has been on the radar for in…
Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Cell Culture Media Bags Market size & share revenue was valued at approximately USD 1.…
This article first appeared on GuruFocus. Group Sales Revenue: EUR899 million, increased by 7.5% in constant currencies and 1.8% reported. Bioprocess Solutions Sales: EUR735 million, increased by 8.1% in constant currencies and 2.4% report…
* Sartorius Aktiengesellschaft press release [https://www.sartorius.com/download/1817684/q1-2026-download-earnings-report-sag-en-data.pdf] (SARTF [https://seekingalpha.com/symbol/SARTF]): Q1 Non-GAAP EPS of €1.20. * Revenue of €899.1M (+1.…
Company Logo Rapid growth in biologics is fueling the biopharmaceutical filtration market. Key opportunities include membrane filtration systems and single-use technologies, with North America and Europe leading. Innovations and mergers in…
GOTTINGEN, GERMANY - March 26, 2026 (NEWMEDIAWIRE) - At today's meeting, the Supervisory Board of Sartorius AG resolved to extend the appointment of Dr. Ren Fber as a member of the Executive Board by a five-year period to December 31, 2031…
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Eveo Cell Therapy Platform launch and why it matters Sartorius (XTRA:SRT3) has drawn investor att…